Welcome to the New Normal
(3-minute read) Businesses need to adapt to our constantly changing world. And I recently revealed which ones will be the winners throughout the pandemic and beyond…
Read More
Tag: COVID-19
A Stock-Picking Mutation to Beat the Omicron Threat
This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
GM’s EV Fantasy, Airlines Knocked For A Loop & Dorsey Dumps Twitter
GM: General Misunderstanding Welcome back, Great Ones! I hope you had a great Thanksgiving break...
Read More
To Win at Investing, Accept That There Is NO Normal
At times of extreme uncertainty, external factors drive the prices of individual stocks. Some are “a bit” predictable, like the actions of the Federal Reserve. Others are true “Black Swans” — completely unpredictable events such as Omicron. In “normal” times, on the other hand, we’re supposed to be able to predict the movement of stock prices using standard models. But what if there are no normal times? A fascinating article by a famous investment analyst convinces me that this is exactly the case.
Omicron: Classic Case of Sell First, Think Later
(4-minute read) Last week, we saw plenty of overreactions to headlines and falling into the groupthink behind knee-jerk market reactions. Here’s how to avoid them and profit instead…
MEET OUR EXPERTS
Director of VIP Services
Editor of Strategic Fortunes and three elite services
Editor of Alpha Investor
Chief Investment Strategist of Money & Markets
Research Analyst
